{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:52:55Z","timestamp":1792644775813,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"37","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation Centre for Research Excellence Grant","doi-asserted-by":"publisher","award":["RE\/18\/6\/342174217"],"award-info":[{"award-number":["RE\/18\/6\/342174217"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000327","name":"Heart Research UK","doi-asserted-by":"publisher","award":["RG2676\/18\/21"],"award-info":[{"award-number":["RG2676\/18\/21"]}],"id":[{"id":"10.13039\/501100000327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Many patients are prescribed loop diuretics without a diagnostic record of heart failure. Little is known about their characteristics and prognosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Glasgow regional health records (2009\u201316) were obtained for adults with cardiovascular disease or taking loop diuretics. Outcomes were investigated using Cox models with hazard ratios adjusted for age, sex, socioeconomic deprivation, and comorbid disease (adjHR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 198 898 patients (median age 65 years; 55% women), 161 935 (81%) neither took loop diuretics nor had a diagnostic record of heart failure (reference group), 23 963 (12%) were taking loop diuretics but had no heart failure recorded, 7844 (4%) had heart failure recorded and took loop diuretics, and 5156 (3%) had heart failure recorded but were not receiving loop diuretics. Compared to the reference group, five-year mortality was only slightly higher for heart failure in the absence of loop diuretics [22%; adjHR 1.2 (95% CI 1.1\u20131.3)], substantially higher for those taking loop diuretics with no record of heart failure [40%; adjHR 1.8 (95% CI 1.7\u20131.8)], and highest for heart failure treated with loop diuretics [52%; adjHR 2.2 (95% CI 2.0\u20132.2)].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>For patients with cardiovascular disease, many are prescribed loop diuretics without a recorded diagnosis of heart failure. Mortality is more strongly associated with loop diuretic use than with a record of heart failure. The diagnosis of heart failure may be often missed, or loop diuretic use is associated with other conditions with a prognosis similar to heart failure, or inappropriate loop diuretic use increases mortality; all might be true.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehae345","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T07:39:47Z","timestamp":1717745987000},"page":"3837-3849","source":"Crossref","is-referenced-by-count":47,"title":["Loop diuretic therapy with or without heart failure: impact on prognosis"],"prefix":"10.1093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1658-3883","authenticated-orcid":false,"given":"Jocelyn M","family":"Friday","sequence":"first","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , 126 University Place, Glasgow, G12 8TA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-7016","authenticated-orcid":false,"given":"John G F","family":"Cleland","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , 126 University Place, Glasgow, G12 8TA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7175-0464","authenticated-orcid":false,"given":"Pierpaolo","family":"Pellicori","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , 126 University Place, Glasgow, G12 8TA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3369-3558","authenticated-orcid":false,"given":"Maria K","family":"Wolters","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , 126 University Place, Glasgow, G12 8TA ,","place":["UK"]},{"name":"Institute for Design Informatics, School of Informatics, University of Edinburgh , Edinburgh ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6317-3975","authenticated-orcid":false,"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , 126 University Place, Glasgow, G12 8TA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4306-5317","authenticated-orcid":false,"given":"Pardeep S","family":"Jhund","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , 126 University Place, Glasgow, G12 8TA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3804-6795","authenticated-orcid":false,"given":"Paul","family":"Forsyth","sequence":"additional","affiliation":[{"name":"Pharmacy Department, NHS Greater Glasgow & Clyde , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-1764","authenticated-orcid":false,"given":"David A","family":"McAllister","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-9958","authenticated-orcid":false,"given":"Fraser J","family":"Graham","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , 126 University Place, Glasgow, G12 8TA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0169-6364","authenticated-orcid":false,"given":"Yola","family":"Jones","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , 126 University Place, Glasgow, G12 8TA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3811-8165","authenticated-orcid":false,"given":"Jim","family":"Lewsey","sequence":"additional","affiliation":[{"name":"School of Health and Wellbeing, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"key":"2024100709450739500_ehae345-B1","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1093\/eurheartj\/ehab082","article-title":"The struggle towards a universal definition of heart failure\u2014how to proceed?","volume":"42","author":"Cleland","year":"2021","journal-title":"Eur Heart J"},{"key":"2024100709450739500_ehae345-B2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10557-016-6697-7","article-title":"Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure","volume":"30","author":"Pellicori","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"2024100709450739500_ehae345-B3","author":"National Institute for Health and Care Excellence"},{"key":"2024100709450739500_ehae345-B4","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"2024100709450739500_ehae345-B5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/eurheartj\/ehac680","article-title":"Assessing and treating congestion in acute decompensated heart failure: are we seeing the light at the end of the tunnel?","volume":"44","author":"Mebazaa","year":"2023","journal-title":"European heart journal"},{"key":"2024100709450739500_ehae345-B6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ije\/dyw060","article-title":"Data resource profile: the Scottish National Prescribing Information System (PIS)","volume":"45","author":"Alvarez-Madrazo","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2024100709450739500_ehae345-B7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"key":"2024100709450739500_ehae345-B8","volume-title":"Scottish Index of Multiple Deprivation 2012","author":"The Scottish Government","year":"2012"},{"key":"2024100709450739500_ehae345-B9","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/ije\/dys188","article-title":"Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)","volume":"41","author":"Denaxas","year":"2012","journal-title":"Int J Epidemiol"},{"key":"2024100709450739500_ehae345-B10","doi-asserted-by":"publisher","first-page":"e004952","DOI":"10.1136\/bmjopen-2014-004952","article-title":"Can analyses of electronic patient records be independently and externally validated? The effect of statins on the mortality of patients with ischaemic heart disease: a cohort study with nested case\u2013control analysis","volume":"4","author":"Reeves","year":"2014","journal-title":"BMJ Open"},{"key":"2024100709450739500_ehae345-B11","volume-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity","author":"World Health Organization","year":"2011"},{"key":"2024100709450739500_ehae345-B12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2024100709450739500_ehae345-B13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2024100709450739500_ehae345-B14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2024100709450739500_ehae345-B15"},{"key":"2024100709450739500_ehae345-B16","author":"Therneau"},{"key":"2024100709450739500_ehae345-B17","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"2024100709450739500_ehae345-B18","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"2024100709450739500_ehae345-B19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ejheart.2007.01.013","article-title":"Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials","volume":"9","author":"Cleland","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2024100709450739500_ehae345-B20","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/ejhf.2220","article-title":"Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial","volume":"23","author":"Pellicori","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2024100709450739500_ehae345-B21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12916-021-02048-8","article-title":"Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study","volume":"19","author":"Zakeri","year":"2021","journal-title":"BMC Med"},{"key":"2024100709450739500_ehae345-B22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2024100709450739500_ehae345-B23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"2024100709450739500_ehae345-B24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.hfc.2014.04.008","article-title":"Phenotypic spectrum of heart failure with preserved ejection fraction","volume":"10","author":"Shah","year":"2014","journal-title":"Heart Fail Clin"},{"key":"2024100709450739500_ehae345-B25","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1016\/j.jacc.2021.04.070","article-title":"Classification of heart failure according to ejection fraction: JACC review topic of the week","volume":"77","author":"Lam","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2024100709450739500_ehae345-B26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/hrt.2010.209171","article-title":"The national heart failure audit for England and Wales 2008\u20132009","volume":"97","author":"Cleland","year":"2011","journal-title":"Heart"},{"key":"2024100709450739500_ehae345-B27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/ejhf.462","article-title":"Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction","volume":"18","author":"Damman","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2024100709450739500_ehae345-B28","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1532-5415.2009.02195.x","article-title":"Loop diuretic use and rates of hip bone loss and risk of falls and fractures in older women","volume":"57","author":"Lim","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"2024100709450739500_ehae345-B29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/art.38203","article-title":"Use of diuretics and risk of incident gout: a population-based case\u2013control study","volume":"66","author":"Bruderer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2024100709450739500_ehae345-B30","doi-asserted-by":"publisher","first-page":"A38","DOI":"10.1016\/0002-9149(86)91005-2","article-title":"Diuretic use in the elderly: potential for diuretic-induced hypokalemia","volume":"57","author":"Flamenbaum","year":"1986","journal-title":"Am J Cardiol"},{"key":"2024100709450739500_ehae345-B31","author":"Public Health Scotland"},{"key":"2024100709450739500_ehae345-B32","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.23889\/ijpds.v4i2.1134","article-title":"A profile of the Sail Databank on the UK secure research platform","volume":"4","author":"Jones","year":"2019","journal-title":"Int J Popul Data Sci"},{"key":"2024100709450739500_ehae345-B33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00228-011-1088-2","article-title":"Utilization of health care databases for pharmacoepidemiology","volume":"68","author":"Takahashi","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"2024100709450739500_ehae345-B34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","article-title":"The Nordic countries as a cohort for pharmacoepidemiological research","volume":"106","author":"Furu","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2024100709450739500_ehae345-B35","author":"Data Quality Assurance"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehae345\/58161078\/ehae345.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/37\/3837\/59616541\/ehae345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/37\/3837\/59616541\/ehae345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T09:45:24Z","timestamp":1728294324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/45\/37\/3837\/7689197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":35,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2024,6,7]]},"published-print":{"date-parts":[[2024,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehae345","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10,1]]},"published":{"date-parts":[[2024,6,7]]}}}